Reaction

Trichophytosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 211 reports · 7 co-occurring drugs

As of the last recalculation, Trichophytosis appears in 211 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 229.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Valganciclovir Hydrochloride Powder,25229.2229.7
Terbinafine Hydrochloride15179.2179.5
Valganciclovir25148.3148.5
Valganciclovir Hydrochloride25148.3148.5
Mycophenilic Acid20105.1105.2
Tacrolimus Ointment 0.1%7897.497.5
Tacrolimus Extended-Release Capsules7897.297.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.